These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

421 related items for PubMed ID: 18442092

  • 1. The chemokine receptor CXCR2 is differentially regulated on glial cells in vivo but is not required for successful remyelination after cuprizone-induced demyelination.
    Lindner M, Trebst C, Heine S, Skripuletz T, Koutsoudaki PN, Stangel M.
    Glia; 2008 Aug 01; 56(10):1104-13. PubMed ID: 18442092
    [Abstract] [Full Text] [Related]

  • 2. Gene expression in brain during cuprizone-induced demyelination and remyelination.
    Morell P, Barrett CV, Mason JL, Toews AD, Hostettler JD, Knapp GW, Matsushima GK.
    Mol Cell Neurosci; 1998 Nov 01; 12(4-5):220-7. PubMed ID: 9828087
    [Abstract] [Full Text] [Related]

  • 3. Chronic toxic demyelination in the central nervous system leads to axonal damage despite remyelination.
    Lindner M, Fokuhl J, Linsmeier F, Trebst C, Stangel M.
    Neurosci Lett; 2009 Apr 03; 453(2):120-5. PubMed ID: 19356606
    [Abstract] [Full Text] [Related]

  • 4. Leukemia inhibitory factor signaling modulates both central nervous system demyelination and myelin repair.
    Marriott MP, Emery B, Cate HS, Binder MD, Kemper D, Wu Q, Kolbe S, Gordon IR, Wang H, Egan G, Murray S, Butzkueven H, Kilpatrick TJ.
    Glia; 2008 Apr 15; 56(6):686-98. PubMed ID: 18293407
    [Abstract] [Full Text] [Related]

  • 5. Lack of interferon-beta leads to accelerated remyelination in a toxic model of central nervous system demyelination.
    Trebst C, Heine S, Lienenklaus S, Lindner M, Baumgärtner W, Weiss S, Stangel M.
    Acta Neuropathol; 2007 Dec 15; 114(6):587-96. PubMed ID: 17940777
    [Abstract] [Full Text] [Related]

  • 6. Cuprizone induces similar demyelination in male and female C57BL/6 mice and results in disruption of the estrous cycle.
    Taylor LC, Gilmore W, Ting JP, Matsushima GK.
    J Neurosci Res; 2010 Feb 01; 88(2):391-402. PubMed ID: 19746424
    [Abstract] [Full Text] [Related]

  • 7. Cuprizone effect on myelination, astrogliosis and microglia attraction in the mouse basal ganglia.
    Pott F, Gingele S, Clarner T, Dang J, Baumgartner W, Beyer C, Kipp M.
    Brain Res; 2009 Dec 11; 1305():137-49. PubMed ID: 19799876
    [Abstract] [Full Text] [Related]

  • 8. Minocycline reduces remyelination by suppressing ciliary neurotrophic factor expression after cuprizone-induced demyelination.
    Tanaka T, Murakami K, Bando Y, Yoshida S.
    J Neurochem; 2013 Oct 11; 127(2):259-70. PubMed ID: 23647102
    [Abstract] [Full Text] [Related]

  • 9. Regional differences between grey and white matter in cuprizone induced demyelination.
    Gudi V, Moharregh-Khiabani D, Skripuletz T, Koutsoudaki PN, Kotsiari A, Skuljec J, Trebst C, Stangel M.
    Brain Res; 2009 Aug 04; 1283():127-38. PubMed ID: 19524552
    [Abstract] [Full Text] [Related]

  • 10. Thyroid hormones promote differentiation of oligodendrocyte progenitor cells and improve remyelination after cuprizone-induced demyelination.
    Franco PG, Silvestroff L, Soto EF, Pasquini JM.
    Exp Neurol; 2008 Aug 04; 212(2):458-67. PubMed ID: 18572165
    [Abstract] [Full Text] [Related]

  • 11. TNF superfamily member TWEAK exacerbates inflammation and demyelination in the cuprizone-induced model.
    Iocca HA, Plant SR, Wang Y, Runkel L, O'Connor BP, Lundsmith ET, Hahm K, van Deventer HW, Burkly LC, Ting JP.
    J Neuroimmunol; 2008 Feb 04; 194(1-2):97-106. PubMed ID: 18207576
    [Abstract] [Full Text] [Related]

  • 12. Alterations in the oligodendrocyte lineage, myelin, and white matter in adult mice lacking the chemokine receptor CXCR2.
    Padovani-Claudio DA, Liu L, Ransohoff RM, Miller RH.
    Glia; 2006 Oct 04; 54(5):471-83. PubMed ID: 16886211
    [Abstract] [Full Text] [Related]

  • 13. Sequential myelin protein expression during remyelination reveals fast and efficient repair after central nervous system demyelination.
    Lindner M, Heine S, Haastert K, Garde N, Fokuhl J, Linsmeier F, Grothe C, Baumgärtner W, Stangel M.
    Neuropathol Appl Neurobiol; 2008 Feb 04; 34(1):105-14. PubMed ID: 17961136
    [Abstract] [Full Text] [Related]

  • 14. CXCR2-positive neutrophils are essential for cuprizone-induced demyelination: relevance to multiple sclerosis.
    Liu L, Belkadi A, Darnall L, Hu T, Drescher C, Cotleur AC, Padovani-Claudio D, He T, Choi K, Lane TE, Miller RH, Ransohoff RM.
    Nat Neurosci; 2010 Mar 04; 13(3):319-26. PubMed ID: 20154684
    [Abstract] [Full Text] [Related]

  • 15. Lipopolysaccharide delays demyelination and promotes oligodendrocyte precursor proliferation in the central nervous system.
    Skripuletz T, Miller E, Grote L, Gudi V, Pul R, Voss E, Skuljec J, Moharregh-Khiabani D, Trebst C, Stangel M.
    Brain Behav Immun; 2011 Nov 04; 25(8):1592-606. PubMed ID: 21635946
    [Abstract] [Full Text] [Related]

  • 16. The cuprizone model: regional heterogeneity of pathology.
    Wergeland S, Torkildsen Ø, Myhr KM, Mørk SJ, Bø L.
    APMIS; 2012 Aug 04; 120(8):648-57. PubMed ID: 22779688
    [Abstract] [Full Text] [Related]

  • 17. Corticosteroids impair remyelination in the corpus callosum of cuprizone-treated mice.
    Clarner T, Parabucki A, Beyer C, Kipp M.
    J Neuroendocrinol; 2011 Jul 04; 23(7):601-11. PubMed ID: 21507085
    [Abstract] [Full Text] [Related]

  • 18. Galectin-3 controls the response of microglial cells to limit cuprizone-induced demyelination.
    Hoyos HC, Rinaldi M, Mendez-Huergo SP, Marder M, Rabinovich GA, Pasquini JM, Pasquini LA.
    Neurobiol Dis; 2014 Feb 04; 62():441-55. PubMed ID: 24184798
    [Abstract] [Full Text] [Related]

  • 19. Astroglial-derived lymphotoxin-alpha exacerbates inflammation and demyelination, but not remyelination.
    Plant SR, Arnett HA, Ting JP.
    Glia; 2005 Jan 01; 49(1):1-14. PubMed ID: 15382206
    [Abstract] [Full Text] [Related]

  • 20. Osteopontin is upregulated during in vivo demyelination and remyelination and enhances myelin formation in vitro.
    Selvaraju R, Bernasconi L, Losberger C, Graber P, Kadi L, Avellana-Adalid V, Picard-Riera N, Baron Van Evercooren A, Cirillo R, Kosco-Vilbois M, Feger G, Papoian R, Boschert U.
    Mol Cell Neurosci; 2004 Apr 01; 25(4):707-21. PubMed ID: 15080898
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.